Gene · 9968
Papers2,273
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,273
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical trajectories and magnetic resonance imaging-based triage of uterine leiomyoma molecular subtypes: a large-scale retrospective analysis of 720 genotyped tumors. | Am J Obstet Gynecol | 2026 | 42692323 | PubTator, text mining | PubMed |
| Genetic-Epigenetic Interactions in Uterine Leiomyomas: MED12 Mutations as Predictors of Aberrant DNA Methylation. | Genes (Basel) | 2026 | 42650070 | PubTator, text mining | PubMed |
| How Often are druggable mutations detectable in Metastatic Castration Resistant Prostate Cancer? | Urol Int | 2026 | 42594033 | PubTator, text mining | PubMed |
| Human Myometrial Cell Fate under Chronic Oxidative Stress for Leiomyomagenesis. | Res Sq | 2026 | 42539031 | PubTator, text mining | PubMed |
| Emerging biomarkers in breast fibroadenoma: implications for differential diagnosis, malignant transformation, and precision medicine. | Mol Biol Rep | 2026 | 42530698 | PubTator, text mining | PubMed |
| Discovery of a potent dual-target CDK8 and cyclin C PROTAC degrader for the treatment of colorectal cancer. | RSC Med Chem | 2026 | 42519713 | PubTator, text mining | PubMed |
| A Novel Intronic Variant in MED12 Associated with a Predominantly Hepatobiliary Phenotype Suggestive of Hardikar Syndrome: A Case Report and Literature Review. | Genes (Basel) | 2026 | 42510827 | PubTator, text mining | PubMed |
| Vitamin D3 ameliorates R-loop-induced replication stress and chromosomal instability in MED12-mutant uterine fibroids. | Sci Rep | 2026 | 42409897 | PubTator, text mining | PubMed |
| Dysregulated methylation-ubiquitination crosstalk accelerates intervertebral disc degeneration via MED12 destabilization and cGAS/STING activation. | J Clin Invest | 2026 | 42378049 | PubTator, text mining | PubMed |
| Genomic Characteristics of Leiomyosarcoma: An AACR Project GENIE Study. | Anticancer Res | 2026 | 42373270 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16INK4A in Controlling TCR-Dependent and Independent CD8 T Cell Expansion. | Eur J Immunol | 2026 | 42345443 | PubTator, text mining | PubMed |
| Clinicopathological and molecular features of uterine smooth muscle tumours in patients with Li-Fraumeni syndrome. | Histopathology | 2026 | 42312930 | PubTator, text mining | PubMed |
| Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cells. | Cell Rep | 2026 | 42275218 | PubTator, text mining | PubMed |
| Landscape of genetic alterations affecting cancer genes in primary and advanced malignant phyllodes tumours. | Histopathology | 2026 | 42236264 | PubTator, text mining | PubMed |
| Multidisciplinary Management of Malignant Phyllodes Tumours of the Breast: A Case-Based Illustration and Systematic Review. | Int J Mol Sci | 2026 | 42196354 | PubTator, text mining | PubMed |
| A Uterine Leiomyoma With a Novel BRAF::ABCB1 t(7; 7)(q34; q21.12) Fusion: A Case Report. | Cureus | 2026 | 42137712 | PubTator, text mining | PubMed |
| Stem cell activation in organ culture reveals novel transcriptional programs underlying metabolic, fibrotic, vascular, and immune dysregulation in uterine leiomyomas. | Front Cell Dev Biol | 2026 | 42099382 | PubTator, text mining | PubMed |
| A Systematic Review of the Role of Senescent Cells in Uterine Leiomyomas: Deciphering Molecular Pathways and Exploring Therapeutic Prospects. | Reprod Sci | 2026 | 42086971 | PubTator, text mining | PubMed |
| Inference of Autism Risk Genes Through Comparative Sociogenomics and Molecular Network Analysis. | Genes (Basel) | 2026 | 42074486 | PubTator, text mining | PubMed |
| Analysis of MED-12 mutations in uterine leiomyomas of Nigerian women. | F S Sci | 2026 | 42069218 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9968/papers